Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Nohria

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|April 1, 1982
Synthesis and dopaminergic properties of some exo- and endo-2-aminobenzonorbornenes designed as rigid analogue of dopamineP Burn, P A Crooks, F Heatley, et al.
Archives of Pediatrics & Adolescent Medicine|January 1, 1995
Erythromycin-induced carbamazepine toxicity: a continuing problemC E Stafstrom, V Nohria, H Loganbill, et al.
Biology of the Neonate|January 1, 1987
Long-term variation in oxygen consumption rate in preterm infantsS B Roberts, P R Murgatroyd, J A Crisp, et al.
Nature|June 19, 1980
(-)N-(chloroethyl)norapomorphine inhibits striatal dopamine function via irreversible receptor bindingB Costall, D H Fortune, S J Law, et al.
British Journal of Pharmacology|February 1, 1981
Differential effect of benserazide (Ro4-4602) on the concentration of indoleamines in rat pineal and hypothalamusJ Arendt, A K Ho, C Laud, et al.
Neurology|October 15, 2010
Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsyM J Brodie, H Lerche, A Gil-Nagel, et al.
Annals of Neurology|March 1, 1994
A splice junction mutation in a new myopathic variant of phosphoglycerate kinase deficiency (PGK North Carolina)S Tsujino, P Tonin, S Shanske, et al.
The Journal of Pharmacy and Pharmacology|August 1, 1980
On the ability of N-chloroethyl aporphine derivatives to cause irreversible inhibition of dopamine receptor mechanismsB Costall, D H Fortune, F E Granchelli, et al.
Neurology|April 1, 2011
Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsyJ A French, B W Abou-Khalil, R F Leroy, et al.
Psychopharmacology|March 1, 1996
Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) studyL S Pilowsky, G F Busatto, M Taylor, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|April 1, 1982
Synthesis and dopaminergic properties of some exo- and endo-2-aminobenzonorbornenes designed as rigid analogue of dopamineP Burn, P A Crooks, F Heatley, et al.
Archives of Pediatrics & Adolescent Medicine|January 1, 1995
Erythromycin-induced carbamazepine toxicity: a continuing problemC E Stafstrom, V Nohria, H Loganbill, et al.
Biology of the Neonate|January 1, 1987
Long-term variation in oxygen consumption rate in preterm infantsS B Roberts, P R Murgatroyd, J A Crisp, et al.
Nature|June 19, 1980
(-)N-(chloroethyl)norapomorphine inhibits striatal dopamine function via irreversible receptor bindingB Costall, D H Fortune, S J Law, et al.
British Journal of Pharmacology|February 1, 1981
Differential effect of benserazide (Ro4-4602) on the concentration of indoleamines in rat pineal and hypothalamusJ Arendt, A K Ho, C Laud, et al.
Neurology|October 15, 2010
Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsyM J Brodie, H Lerche, A Gil-Nagel, et al.
Annals of Neurology|March 1, 1994
A splice junction mutation in a new myopathic variant of phosphoglycerate kinase deficiency (PGK North Carolina)S Tsujino, P Tonin, S Shanske, et al.
The Journal of Pharmacy and Pharmacology|August 1, 1980
On the ability of N-chloroethyl aporphine derivatives to cause irreversible inhibition of dopamine receptor mechanismsB Costall, D H Fortune, F E Granchelli, et al.
Neurology|April 1, 2011
Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsyJ A French, B W Abou-Khalil, R F Leroy, et al.
Psychopharmacology|March 1, 1996
Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) studyL S Pilowsky, G F Busatto, M Taylor, et al.
Pageof 4